• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Andrew S. Chi


  • Chi AS, Batchelor TT, Yang D, Dias-Santagata D, Borger DR, Ellisen LW, Iafrate AJ, Louis DN.BRAF V600E mutation identifies a subset of low-grade diffusely infiltrating gliomas in adults.J Clin Oncol. 2013 May 10;31(14):e233-6.
  • Chi AS, Batchelor TT, Dias-Santagata D, Borger D, Stiles CD, Wang DL, Curry WT, Wen PY, Ligon KL, Ellisen L, Louis DN, Iafrate AJ.Prospective, high-throughput molecular profiling of human gliomas.J. Neurooncol. 2012 Oct;110(1):89-98.
  • Mendenhall EM, Koche RP, Truong T, Zhou VW, Issac B, Chi AS, Ku M, Bernstein BE.GC-rich sequence elements recruit PRC2 in mammalian ES cells.PLoS Genet. 2010;6(12):e1001244.
  • Chi AS, Norden AD, Wen PY.Antiangiogenic strategies for treatment of malignant gliomas.Neurotherapeutics : The Journal Of The American Society For Experimental Neuro Therapeutics. 2009 Jul;6(3):513-26. Review.
  • Chi AS,Sorensen AG,Jain RK,Batchelor TT.Angiogenesis as a Therapeutic Target in Malignant Gliomas.Oncologist. 2009 Jun;14(6):621-36. Review.
  • Chi AS,Bernstein BE.Developmental biology. Pluripotent chromatin state.Science. 2009 Jan 9;323(5911):220-1.
  • Ku M,Koche RP,Rheinbay E,Mendenhall EM,Endoh M,Mikkelsen TS,Presser A,Nusbaum C,Xie X,Chi AS,Adli M,Kasif S,Ptaszek LM,Cowan CA,Lander ES,Koseki H,Bernstein BE.Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains.PLoS Genet. 2008 Oct;4(10):e1000242.
  • Chi A, Norden AD, Wen PY.Inhibition of angiogenesis and invasion in malignant gliomas.Expert Rev Anticancer Ther. 2007 Nov;7(11):1537-60. Review.
  • Chi AS, Wen PY.Inhibiting kinases in malignant gliomas.Expert Opin Ther Targets. 2007 Apr;11(4):473-96. Review.
  • Chi AS,Deng Z,Albach RA,Kemp RG.The two phosphofructokinase gene products of Entamoeba histolytica.J Biol Chem. 2001 Jun 8;276(23):19974-81.
  • Chi A,Kemp RG.The primordial high energy compound: ATP or inorganic pyrophosphate?.J Biol Chem. 2000 Nov 17;275(46):35677-9.